rheumatoid arthritis
| 4 min read
Elizabeth Laws leads Sanofi’s inflammation and immunology development pipeline to test the first oral TNFR1 inhibitor for rheumatoid arthritis and psoriasis.
| 10+ min read
Once symptoms show up, it’s too late to cure many autoimmune diseases. Researchers are investigating ways to prevent the conditions from starting at all.
| 3 min read
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
| 6 min read
Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs.
Available on Demand
Re-engineering immune cells helps reverse immune dysregulation associated with autoimmune diseases.
| 3 min read
The European Commission has approved AbbVie’s RINVOQ (upadacitinib) for treatment of psoriatic arthritis and ankylosing spondylitis
Page 1 of 1 - 6 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
